| 产品名称 | ReVacc Scientific A46U23 | West Nile virus Reporter Virus Particle (RVP) with Renilla Luciferase Reporter (NY99 Strain) |
|---|---|
| 目录号 | A46U23 |
| 别名 | West Nile virus Reporter Virus Particle (RVP) with Renilla Luciferase Reporter (NY99 Strain) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| A46U23 | 200 μl; 1000 μl | 咨询 | 咨询 |
ReVacc Scientific A46U23 | West Nile virus Reporter Virus Particle (RVP) with Renilla Luciferase Reporter (NY99 Strain)
品名：West Nile virus Reporter Virus Particle (RVP) with Renilla Luciferase Reporter (NY99 Strain)
货号：A46U23
品牌：ReVacc Scientific
规格：200 μl; 1000 μl
产品描述
Organism：West Nile Virus (WNV)
Reporter virus particles (RVPs) package the capsid-preMembrane-envelope (C-prM-E) gene construct of West Nile Virus (WNV) (GenBank: DQ211652.1, NY99 strain) and a Renilla luciferase reporter. As the wild typed WNV is handled under BSL 2 precautions, this WNV RVP can be handled using BSL-2 containment practices. Infection of cells with this RVP carrying Renilla luciferase reporter results in high level Renilla luciferase activity. See our titration result showing that the starting 2-fold diluted RVP-infected target cells (Vero) generates signal ~ 10,000-fold higher than uninfected control (cell alone as background in blue). We also evaluated the neutralizing activity of one known neutralizing monoclonal antibody– E60 that binds to domain DI/DII region of the viral envelope protein. See figure
